Trial intelligence / Profile preview

Ketamine vs Dexmedetomidine for Postoperative Pain in Abdominal Cancer Surgery

NCT02927379Phase 3Completed

Sponsor
Assiut University
Start
Jun 2016
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ketamine and dexmedetomidine in postoperative pain (3 arms), sponsored by Assiut University. Primary endpoint: Total morphine consumption at 24 hours. Started Jun 2016; status: completed.

02

Drugs

ketaminedexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02927379.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02927379.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call